INSCOPIX, INC.

Inscopix, Inc. specializes in the design, manufacturing, and maintenance of advanced miniature imaging systems for biomedical research and clinical applications. The company develops precision optical instrumentation, including endoscopic and miniscope platforms for in vivo imaging, with a focus on dual-color neural recording and high-resolution tissue visualization. Their technical expertise spans analytical laboratory instrument manufacturing, electronic system calibration, and precision equipment servicing, particularly for neuroscientific and surgical research environments. Inscopix differentiates itself through proprietary imaging hardware such as the NVUE 2.0 system, integrated lens assemblies, and custom commutator designs that enable stable, long-duration neural data acquisition in freely moving subjects—critical for behavioral neuroscience and preclinical studies. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, delivering imaging systems and maintenance services primarily to NIH institutes including NICHD and NIAAA. Work for HHS centers on supporting cutting-edge life science research with validated, field-deployable instrumentation. A single contract with the Department of Veterans Affairs indicates limited but targeted engagement in medical device coverage and evaluation. Inscopix operates primarily within analytical laboratory instrument manufacturing and research and development in the life sciences, positioning itself as a niche supplier of engineered optical systems for neurobiology and surgical innovation. Their work bridges engineering precision with biological application, serving academic, government, and translational research markets that demand miniaturized, high-fidelity imaging solutions. As a small business structured as a 2L entity based in Mountain View, California, Inscopix leverages its proximity to Silicon Valley’s innovation ecosystem to deliver specialized hardware solutions. The company holds no federal certifications but maintains technical credibility through direct, mission-critical delivery of proprietary imaging platforms to federal research stakeholders.